MoneyWorks4Me

Procter&Gamble Healt - Quaterly Results

06 Nov 2025 Evaluate
The quarter ended September 2025 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 3249.20 millions.Modest increase of 7.54% in the Net Profit was reported from. 823.30 millions to Rs. 885.40  millions.OP of the company witnessed a marginal growth to 1252.20 millions from 1173.20 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202509 202409 % Var 202509 202409 % Var 202406 202306 % Var
Sales 3249.20 3134.10 3.67 15978.30 14646.70 9.09 11512.60 12296.20 -6.37
Other Income 49.50 32.80 50.91 193.30 189.10 2.22 156.30 183.90 -15.01
PBIDT 1252.20 1173.20 6.73 5483.30 4389.50 24.92 3216.30 3430.70 -6.25
Interest 1.20 1.50 -20.00 6.70 8.70 -22.99 7.20 7.70 -6.49
PBDT 1251.00 1171.70 6.77 5476.60 4178.90 31.05 3007.20 3423.00 -12.15
Depreciation 60.80 57.70 5.37 282.10 331.70 -14.95 274.00 281.00 -2.49
PBT 1190.20 1114.00 6.84 5194.50 3847.20 35.02 2733.20 3142.00 -13.01
TAX 304.80 290.70 4.85 1303.20 1014.10 28.51 723.40 847.30 -14.62
Deferred Tax -0.60 11.20 -105.36 -8.60 -74.80 -88.50 -86.00 -50.60 69.96
PAT 885.40 823.30 7.54 3891.30 2833.10 37.35 2009.80 2294.70 -12.42
Equity 166.00 166.00 0.00 166.00 166.00 0.00 166.00 166.00 0.00
PBIDTM(%) 38.54 37.43 2.95 34.32 29.97 14.51 27.94 27.90 0.13
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..